MANILA – The third phase of the World Health Organization (WHO) Solidarity Trial on possible coronavirus disease 2019 (Covid-19) vaccines in the Philippines will start in December.
Department of Health (DOH) Undersecretary Maria Rosario Vergeire, in a recent virtual media forum, said the “WHO has given a commitment that the announcement of the (clinical trial) sites and other details will be given within this week,”
Vergerie said the Russian vaccine manufacturer Gamaleya is still in talks with a Philippine-based contract research organization which may represent Gamaleya for possible local manufacturing of anti-Covid-19 vaccine.
The the Chinese vaccine Sinovac has, meanwhile, been cleared for Covid-19 clinical trials by the Vaccine Expert Panel of the Department of Science and Technology, but Vergeire said its manufacturer would still have to get approval from the Ethics Board before applying for Food and Drug Administration clinical trial clearance.
Earlier, the government has allotted P2.5 billion for the purchase of Covid-19 vaccines under the proposed 2021 national budget.
On Monday, the DOH logged 1,607 new confirmed cases, bringing the total number of active cases to 36,333.
The health department also said 245 more Covid-19 patients have recovered, increasing the country’s total recoveries to 328,258.